Changing patterns of etiology and resistance in community-acquired respiratory tract infections

Infectious Diseases in Clinical Practice

Volumn 7, Issue SUPPL. 2, 1998, Pages

  Garau, Javier ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALOTIN; CEFDINIR; CEFEPIME; CEFIXIME; CEFONICID; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; LATAMOXEF; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CONFERENCE PAPER; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PENICILLIN RESISTANCE; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0031842334     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199808002-00007     Document Type: Conference Paper

References (26)

1. Musher D. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992;14:801-7.
2. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial sensitivity tests for bacteria that grow aerobically. 2nd ed. Approved standard. Vol. 10, No. 8. Villanova (PA): National Committee for Clinical Laboratory Standards; 1990. Document K7-A2.
3. Jacobs MR, Appelbaum PC. Antibiotic resistant pneumococci. Rev Med Microbiol 1995;6:77-93.
4. Kai Man Kam, Kit Yee Luey, Sze Nan Fung, et al. Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 1995;39:2667-70
5. Liñares J, Alonso T, Pérez JL, et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother 1992;30: 279-88.
6. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997;24(1 Suppl):85-8.
7. Dowson CG, Coffey TJ, Spratt BG. Origin and molecular epidemiology of penicillin-binding protein-mediated resistance to β-lactam antibiotics. Trends Microbiol 1994; 2:361-6.
8. Klugman K, Goldstein F, Kohno S, et al. The role of fourth generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997;3(1 Suppl):848-60
9. Nava JN, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994;19:884-90.
10. Goldstein F, Garau J. Resistant pneumococci: a renewed threat in respiratory infections Scand J Infect Dis 1994;93 (Suppl):55-62.
11. Banquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study J Antimicrob Chemother 1996; 38(Suppl A):117-32.
12. Doern GV. Trends in antimicrobial susceptibility of pathogens of the respiratory tract. Am J Med 1995;99(6B Suppl):3-7.
13. Deulofeu F, Nava JN, Bella F, et al. Prospective epidemiological study of invasive Haemophilus influenzae disease in adults. Eur J Clin Microbiol Infect Dis 1994; 13:633-8.
14. Del Castillo F, Garcia-Perea A, Banquero-Artigao F. Bacteriology of acute otitis media in Spain: a prospective study based on tympanocentesis. Pediatr Infect Dis J 1996;15:541-3.
15. Nuovinen P. Increased rates of resistance to trimethoprim. Clin Infect Dis 1997;24(1 Suppl):63-6.
16. Colligon PJ, Bell JM, MacInness SJ, et al. The Australian Group for Antimicrobial Resistance (AGAR): a national, collaborative study of resistance to antimicrobial agents in Haemophilus influenzae in Australian hospitals. J Antimicrob Chemother 1992,30:153-63.
17. George MJ, Kitch B, Henderson FW, et al. In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center. Antimicrob Agents Chemother 1991;35:1960-4.
18. Kaysev FH, Morenzoni G, Santanan P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1990;9:810-7.
19. Bluestone CD, Stephenson JS, Martin LH. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992;11:S7-S11.
20. Nissinen A, Grönroos, Houvinen P, et al. Development of β-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis 1995;21:1193-6.
21. Malnivall BE, Brorson JE, Johnsson J. In vitro sensitivity to penicillin V and ß-lactamase production of Moraxella catarrhalis). J Antimicrob Chemother 1977;3:374-5
22. Jorgensen JH, Doern GV, Maher LA, et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae in the United States Antimicrob Agents Chemother 1990;34:2075-80.
23. Fung CP, Powell M, Seymor A, et al. The antimicrobial susceptibility of Moraxella catarrhalis isolates in England and Scotland in 1991. J Antimicrob Chemother 1992; 30:47-55.
24. Vaneechoutte M, Verachraegan G, Claeis G, et al. Respiratory tract carrier rates of Moraxella catarrhalis in adults and children and interpretation of isolation of M catarrhalis from sputum. J Clin Microbiol 1990;28:2674-80.
25. Christensen JJ, Keiding J, Bruun B. Antimicrobial susceptibility and β-lactamase characterization of Moraxella catarrhalis isolates from 1983/1984 and 1988. APMIS 1990; 98:1039-44.
26. Baquero F, Canton R, Baquero-Artigao F. Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media. Clin Microbiol Infect 1997:3(3 Suppl):1-8.